1Lu L, Katsaros D, Wiley A, et al. Promoter-specific transcription of insulin like-growth factor in epithelial ovarian cancer [ J ]. Gyneeol Oneol, 2006, 103(3) :990 -995. 被引量：1
2Sachdev D, Yee D. Disrupting insulin-like growth factor signaling as a potential cancer therapy[ J]. Mol Cancer Ther,2007,6 : 1 - 12. 被引量：1
3Shen MR, Hsu YM, Hsu KF, et al. Insulin like growth factor 1 is a potent stimulator of cervical cancer cell invasiveness and proliferation that is modulated by alphavbeta3 integrin signaling[ J ]. Carcinogene- sis,2006,27 ( 5 ) :962 - 971. 被引量：1
4RC Barter. Signaling pathway involved in antiproliferative effects of IGFBP-3 : a review[ J]. Clin Pathol : Mol Patho1,2001,54 : 145 - 148. 被引量：1
5Liu B, Lee K W, Anzo M, et al. Insulin-like growth factor-binding protein-3 inhibition of prostate cancer growth involves suppression of angiogenesis [ J ]. Oncogene,2007,26 : 1811 - 1819. 被引量：1
6Kawasaki T Nosho K Ohnishi M, et al. IGFBP3 promoter methylation in colorectal cancer: relationship with microsatellite instability, CpG Island methylator phenotype and p53 [ J ]. Neoplasia, 2007,9 ( 12 ) : 1091 - 1098. 被引量：1
7Fu P, Thompson J A, Bach LA. Promotion of cancer cell migration : an insulin like growth factor (IGF) -independent action of IGF-bind- ing protein-6 [ J]. Biol Chem,2007,282 (31 ) :22298 - 22306. 被引量：1
8Gotlied WH, Bruchim I, Gu J, et al. Insulin-like growth factor re- ceptor I targeting in epithelial ovarian cancer [J]. Gynecol Oncol, 2006,100(2) :389 -396. 被引量：1
9Lukanova A, Lundin E, Toniolo P, et al. Circulating leveloinsulin-lik- growth factor-I and risk of ovarian Ccancer[ J ]. Int Cancer,2002,101 (6) :549-554. 被引量：1
10Lu L, Katsaros D, Wiley A, et al. Promoter-specific transcription of insulin-like growth factor in epithelial ovarian cancer[J].Gynecol Oncol,2006,103 (3) :990 - 995. 被引量：1
7[2]LRoeith D,Roberts CT.The insulin-like growth factor system and cancer[J].Cancer Lett,2003,195 (2):127-137. 被引量：1
8[3]Deming SL,Ren Z,Cai Q,et al.IGF-Ⅰ and IGF-Ⅱ genetic variation and breast cancer risk in Chinese women:results from the Shanghai Breast Cancer Study[J].Cancer Epidemiol Biomarkers Prey,2008,17 (1):255-257. 被引量：1
9[4]Subbi P,Mathur SP,Rajesh S,et al.Circulating level of insulin-like growth factor-Ⅱand IGF-binding protein 3 in cervical cancer[J].Gynecol Oncol,2003,91(2):486-490. 被引量：1
10[5]Sayer RA,Lancaster JM,Pit:man J,et al.High insulin-like growth factor-2 (IGF-2) gene expression is an independent predictor of poor survival for patients with advanced stage serous epithelial ovarian cancer[J].Gynecol Oncol,2005,96(2):355-361. 被引量：1
3Sachdev D, Yee D. Disrupting insulin-like growth factor signaling as a potential cancer therapy [ J ]. Mol Cancer T- her,2007,6( 1 ) :1-12. 被引量：1
4Sachdev D. Regulation of breast cancer metastasis by IGF signaling[ J]. J Mammary Gland Biol Neoplasia,2008,13 (4) :431-441. 被引量：1
5LeRoith D, Roberts CT Jr. The insulin-like growth factor system and cancer[ J ]. Cancer Lett, 2003,195 (2) : 127- 137. 被引量：1
6Zhang Y, Moerkens M, Ramaiahgari S, et al. Elevated in- sulin-like growth factor 1 receptor signaling induces an- tiestrogen resistance through the MAPK/ERK and PI3K/ Akt signaling routes [ J ]. Breast Cancer Res, 2011, 13(3) :R52. 被引量：1
8Eckstein N, Servan K, Hildebrandt B, et al. Hyperactiva- tion of the insulin-like growth factor receptor I signaling pathway is an essential event for cisplatin resistance of o- varian cancer cells [ J ]. Cancer Res, 2009,69 ( 7 ) : 2996- 3003. 被引量：1
9Yee D, Morales FR, Hamilton TC, et al. Expression of in- sulin-like growth factor I, its binding proteins, and its re- ceptor in ovarian cancer [ J ]. Cancer Res, 1991,51 ( 19 ) : 5107-5112. 被引量：1
10Spentzos D, Cannistra SA, Grall F, et al. IGF axis gene ex- pression patterns are prognostic of survival in epithelial o- varian cancer [ J ]. Endocr Relat Cancer, 2007, 14 ( 3 ) : 781-790. 被引量：1
